Oncology & Cancer

Diabetes drug takes aim at cancer's fuel source

In the last three years, researchers have shown that diabetic patients with head and neck cancer, may have better outcomes than non-diabetic patients when they are taking the drug metformin for their diabetes. In order to ...

Diabetes

Exenatide, pioglitazone effective for poorly controlled T2DM

(HealthDay)—For patients with long-standing poorly controlled type 2 diabetes mellitus (T2DM) on metformin plus a sulfonylurea, combination therapy with exenatide and pioglitazone is effective and safe, according to a study ...

Diabetes

Glyburide, metformin have similar effect in gestational DM

(HealthDay)—For patients with gestational diabetes mellitus (GDM), glyburide and metformin are comparable in terms of glucose control and safety, according to a study published online Jan. 11 in Diabetes Care.

Diabetes

Metformin tied to better clinical outcomes in CKD, CHF, CLD

(HealthDay)—For patients with chronic kidney disease (CKD), congestive heart failure (CHF), or chronic liver disease (CLD) with hepatic impairment, metformin use is associated with improvements in clinical outcomes, according ...

Diabetes

Metformin still best as first type 2 diabetes treatment

(HealthDay)—Newly updated guidelines reaffirm that metformin is the first-line drug for people with type 2 diabetes, and that several other medications—including newer ones—can be added if needed.

page 16 from 32